189 related articles for article (PubMed ID: 28069535)
1. Thyronamines and Analogues - The Route from Rediscovery to Translational Research on Thyronergic Amines.
Chiellini G; Bellusci L; Sabatini M; Zucchi R
Mol Cell Endocrinol; 2017 Dec; 458():149-155. PubMed ID: 28069535
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists.
Chiellini G; Nesi G; Digiacomo M; Malvasi R; Espinoza S; Sabatini M; Frascarelli S; Laurino A; Cichero E; Macchia M; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S
J Med Chem; 2015 Jun; 58(12):5096-107. PubMed ID: 26010728
[TBL] [Abstract][Full Text] [Related]
3. Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5.
Dinter J; Mühlhaus J; Wienchol CL; Yi CX; Nürnberg D; Morin S; Grüters A; Köhrle J; Schöneberg T; Tschöp M; Krude H; Kleinau G; Biebermann H
PLoS One; 2015; 10(2):e0117774. PubMed ID: 25706283
[TBL] [Abstract][Full Text] [Related]
4. 3-iodothyronamine differentially modulates α-2A-adrenergic receptor-mediated signaling.
Dinter J; Mühlhaus J; Jacobi SF; Wienchol CL; Cöster M; Meister J; Hoefig CS; Müller A; Köhrle J; Grüters A; Krude H; Mittag J; Schöneberg T; Kleinau G; Biebermann H
J Mol Endocrinol; 2015 Jun; 54(3):205-16. PubMed ID: 25878061
[TBL] [Abstract][Full Text] [Related]
5. Normal thermoregulatory responses to 3-iodothyronamine, trace amines and amphetamine-like psychostimulants in trace amine associated receptor 1 knockout mice.
Panas HN; Lynch LJ; Vallender EJ; Xie Z; Chen GL; Lynn SK; Scanlan TS; Miller GM
J Neurosci Res; 2010 Jul; 88(9):1962-9. PubMed ID: 20155805
[TBL] [Abstract][Full Text] [Related]
6. Trace amine-associated receptor agonists: synthesis and evaluation of thyronamines and related analogues.
Hart ME; Suchland KL; Miyakawa M; Bunzow JR; Grandy DK; Scanlan TS
J Med Chem; 2006 Feb; 49(3):1101-12. PubMed ID: 16451074
[TBL] [Abstract][Full Text] [Related]
7. Cardiac effects of trace amines: pharmacological characterization of trace amine-associated receptors.
Frascarelli S; Ghelardoni S; Chiellini G; Vargiu R; Ronca-Testoni S; Scanlan TS; Grandy DK; Zucchi R
Eur J Pharmacol; 2008 Jun; 587(1-3):231-6. PubMed ID: 18486124
[TBL] [Abstract][Full Text] [Related]
8. 3-Iodothyronamine and Derivatives: New Allies Against Metabolic Syndrome?
Rutigliano G; Bandini L; Sestito S; Chiellini G
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183490
[TBL] [Abstract][Full Text] [Related]
9. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
[TBL] [Abstract][Full Text] [Related]
10. Trace Amine-Associated Receptor 1 Localization at the Apical Plasma Membrane Domain of Fisher Rat Thyroid Epithelial Cells Is Confined to Cilia.
Szumska J; Qatato M; Rehders M; Führer D; Biebermann H; Grandy DK; Köhrle J; Brix K
Eur Thyroid J; 2015 Sep; 4(Suppl 1):30-41. PubMed ID: 26601071
[TBL] [Abstract][Full Text] [Related]
11. Hit-to-Lead Optimization of Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists with a Diphenylmethane-Scaffold: Design, Synthesis, and Biological Study.
Chiellini G; Nesi G; Sestito S; Chiarugi S; Runfola M; Espinoza S; Sabatini M; Bellusci L; Laurino A; Cichero E; Gainetdinov RR; Fossa P; Raimondi L; Zucchi R; Rapposelli S
J Med Chem; 2016 Nov; 59(21):9825-9836. PubMed ID: 27731647
[TBL] [Abstract][Full Text] [Related]
12. Thyronamines and Derivatives: Physiological Relevance, Pharmacological Actions, and Future Research Directions.
Hoefig CS; Zucchi R; Köhrle J
Thyroid; 2016 Dec; 26(12):1656-1673. PubMed ID: 27650974
[TBL] [Abstract][Full Text] [Related]
13. Exploring the structure-activity relationship of the ethylamine portion of 3-iodothyronamine for rat and mouse trace amine-associated receptor 1.
Tan ES; Miyakawa M; Bunzow JR; Grandy DK; Scanlan TS
J Med Chem; 2007 Jun; 50(12):2787-98. PubMed ID: 17497842
[TBL] [Abstract][Full Text] [Related]
14. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.
Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H
Front Pharmacol; 2018; 9():222. PubMed ID: 29593543
[TBL] [Abstract][Full Text] [Related]
15. Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration.
Tremmel E; Hofmann S; Kuhn C; Heidegger H; Heublein S; Hermelink K; Wuerstlein R; Harbeck N; Mayr D; Mahner S; Ditsch N; Jeschke U; Vattai A
Breast Cancer (Dove Med Press); 2019; 11():87-97. PubMed ID: 30858725
[TBL] [Abstract][Full Text] [Related]
16. Update on 3-iodothyronamine and its neurological and metabolic actions.
Zucchi R; Accorroni A; Chiellini G
Front Physiol; 2014; 5():402. PubMed ID: 25360120
[TBL] [Abstract][Full Text] [Related]
17. 3-Iodothyronamine-A Thyroid Hormone Metabolite With Distinct Target Profiles and Mode of Action.
Köhrle J; Biebermann H
Endocr Rev; 2019 Apr; 40(2):602-630. PubMed ID: 30649231
[TBL] [Abstract][Full Text] [Related]
18. 3-Iodothyronamine Induces Diverse Signaling Effects at Different Aminergic and Non-Aminergic G-Protein Coupled Receptors.
Biebermann H; Kleinau G
Exp Clin Endocrinol Diabetes; 2020 Jun; 128(6-07):395-400. PubMed ID: 31698479
[TBL] [Abstract][Full Text] [Related]
19. Distribution of exogenous [125I]-3-iodothyronamine in mouse in vivo: relationship with trace amine-associated receptors.
Chiellini G; Erba P; Carnicelli V; Manfredi C; Frascarelli S; Ghelardoni S; Mariani G; Zucchi R
J Endocrinol; 2012 Jun; 213(3):223-30. PubMed ID: 22442117
[TBL] [Abstract][Full Text] [Related]
20. Thyronamines inhibit plasma membrane and vesicular monoamine transport.
Snead AN; Santos MS; Seal RP; Miyakawa M; Edwards RH; Scanlan TS
ACS Chem Biol; 2007 Jun; 2(6):390-8. PubMed ID: 17530732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
